|
|
Making Sense of the CDC’s New COVID-19 Guidelines
After over two and a half years of dealing and coping with COVID-19, everyone is looking for simpler and more effective guidance to stay as safe as possible and to lessen anxiety in social settings. In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie makes sense of the CDC’s new COVID-19 guidelines by elaborating on the implications of recommendations vs mandates, by adapting new COVID-19 guidance specifically for myeloma patients, and by emphasizing the need for continued prudence to avoid being infected with COVID-19.
|
|
|
|
|
|
|
Now Accepting Applications: The 2023 Brian D. Novis Research Grants
The Brian D. Novis Research Grant was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is September 1, 2022.
|
|
|
|
|
|
|
Summary Report: The 2022 GMAN Summit
This year’s annual Global Myeloma Action Network (GMAN) Summit was held in person from May 20-22, with over 30 representatives of international organizations from 30 countries serving the global myeloma community in attendance. Some highlights of the summit: 2020 Susie Novis Durie (SND) Grant recipients shared outcomes of their projects; 2021 Susie Novis Durie Grant recipients were announced; Breakout sessions focused on starting and sustaining myeloma groups in new regions, as well as which GMAN working groups are needed. To learn more, read the complete summary report.
|
|
|
|
|
|
|
August is National Make-a-Will Month
Get started today by using this free online resource to create your will and protect what matters most – while creating a legacy with the International Myeloma Foundation (IMF).
|
|
|
|
|
|
|
This Week: IMF Patient & Family Webinar—Back to Basics: From Testing to Tailored Therapy
The IMF Patient & Family Webinar (PFW) – Back to Basics: From Testing to Tailored Therapy will be held this Saturday, August 20 at 10 a.m. PST/11 a.m. MST/12 p.m. CT/ 1 p.m. ET. IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie will moderate presentations from the following myeloma experts: Paul Richardson, MD (Dana-Farber Cancer Institute—Boston, MA); Saad Usmani, MD (Memorial Sloan Kettering Cancer Center—New York, NY); and IMF Nurse Leadership Board (NLB) Member Mary Steinbach, DNP, APRN (Huntsman Cancer Institute—Salt Lake City, UT). Topics to be discussed include Recommended Testing and Monitoring: 2022 Algorithms, Frontline Options, Managing Myeloma Care, and Relapse Options: FDA Approved/Clinical Trials. The webinar will conclude with a summary panel discussion, a webinar survey, and closing remarks. At the end of presentations, participants will have time to ask questions.
|
|
|
|
|
|
|
6th Nursing Symposium on August 25 at the 19th IMS Annual Meeting
The 6th Nursing Symposium will be held on Thursday, August 25 (live stream and in-person) during the 19th International Myeloma Society Annual Meeting in Los Angeles, CA. IMF Nurse Leadership Board (NLB) members will be presenting during the sessions: Tiffany Richards, PhD, ANP-BC, AOCNP® (MD Anderson Cancer Center—Houston, TX); Donna Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System—New York, NY); Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN (Cleveland Clinic Taussig Cancer Institute—Cleveland, OH); Sandra Rome, RN, MN, AOCN, CNS (Cedars-Sinai Medical Center—Los Angeles, CA); Daniel Verina, DNP, ACNP-BC (Mount Sinai Medical Center—New York, NY); and NLB International Affiliate Tracy King, PhD, MN, RN (Royal Prince Alfred Hospital—New South Wales, Australia). Sessions include Challenges in Myeloma Patient Management, Oral Abstracts 1 & 2, and Myeloma Clinical Challenges. To know more, visit the 19th IMS Annual Meeting website.
|
|
|
|
|
|
|
4th Annual Inland Empire/Virtual/In Person Walk for Myeloma Miracles
The 4th Annual Inland Empire/Virtual/In Person Walk for Myeloma Miracles will be held on Saturday, September 24, 9:00 a.m. PST at Central Park in Rancho Cucamonga, CA. There are several ways to support this event. You may register as a participant or a team member, donate to a participant or a team, or purchase a Remembrance Path. Donations will also be accepted on the day of the event. Everyone is encouraged to run, walk, bike, or treadmill their own path to complete the Virtual Walk/In Person for Myeloma Miracles. For more information or to register, visit https://fundraising.myeloma.org/myeloma-miracles.
|
|
|
|
|
|
|
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
What should myeloma patients know about bispecific antibodies?
|
|
|
|
|
|
Instagram @IMFmyeloma